Fiocruz expects to receive on Saturday API to manufacture 10 million doses of vaccine

RIO DE JANEIRO, BRAZIL – The Oswaldo Cruz Foundation (Fiocruz) informed on Wednesday, in a press release, that a new shipment of Active Pharmaceutical Ingredient (API), used to produce the covid-19 Oxford/AstraZeneca type vaccines, is expected to be received this Saturday.

According to the foundation’s calculations, the volume will be enough to produce about 10 million doses of the immunizer.

According to Fiocruz, the delivery will be made for vaccine production at the Foundation’s manufacturing unit at the Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz).

In practice, the new shipment will enable deliveries in August, after the final processing and quality control stages are completed. Fiocruz also informed that it expects new API shipments next month.

Related coverage: Over 10,000 species risk extinction in Amazon rainforest, says landmark report · Portuguese police arrest suspect in murder of Brazilian in Lisbon · Brazil's Economy Minister removes real estate funds from tax reform to preserve the industry · Brazil has three weeks of downward trend in Covid-19 cases and deaths – Fiocruz

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

Brazil runoff, Sunday, October 25: Brazil runoff date. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.